Schmitt Daniel Minsider trades

In SEC Form 4 filings, Schmitt Daniel M is listed as President, CEO and Director of Actuate Therapeutics, Inc. (ACTU). In the last 90 days, Schmitt Daniel M bought $50K of Actuate Therapeutics, Inc. (ACTU) on the open market and sold none. The purchase was $50K of Actuate Therapeutics, Inc. (ACTU) on Oct 28.

Companies and roles

Company	Role	Transactions	Last filed
ACTUActuate Therapeutics, Inc.	President, CEO and Director	2	Oct 29

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-10-29

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
ACTUActuate Therapeutics, Inc.	Oct 28	Oct 29	P	140,844	$0.36	Purchase +$50,000	442,560	No	Form 4
ACTUActuate Therapeutics, Inc.	Oct 28	Oct 29	P · derivative	70,422	$0.45	Purchase +$31,690	70,422	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.